Novel Benzimidazole–Oxadiazole Derivatives as Anticancer Agents with VEGFR2 Inhibitory Activity: Design, Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies
Saved in:
| Main Authors: | Ulviye Acar Çevik, Ismail Celik, Şennur Görgülü, Zeynep Deniz Şahin İnan, Hayrani Eren Bostancı, Arzu Karayel, Yusuf Özkay, Zafer Asım Kaplancıklı |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-02-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.4c08885 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthesis, characterization, antimicrobial, antioxidant, and anti-cancer activity of new hybrid structures based on benzimidazole and thiadiazole
by: Hayrani Eren Bostancı, et al.
Published: (2025-01-01) -
Targeting Cancer with New Morpholine-Benzimidazole-Oxadiazole Derivatives: Synthesis, Biological Evaluation, and Computational Insights
by: Gresa Halimi Syla, et al.
Published: (2025-07-01) -
Synthesis, α‑Glucosidase, α‑Amylase, and Aldol Reductase Inhibitory Activity with Molecular Docking Study of Novel Imidazo[1,2‑a]pyridine Derivatives
by: Betül Kaya, et al.
Published: (2024-10-01) -
Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1,3,4-Thiadiazole Derivatives Targeting Both Aldose Reductase and α‑Glucosidase for Diabetes Mellitus
by: Betül Kaya, et al.
Published: (2025-05-01) -
Green synthesis and in vitro anticancer evaluation of 1,2-disubstituted benzimidazole derivatives
by: Alcives Avila-Sorrosa, et al.
Published: (2025-03-01)